Work

How else can we approach prostate cancer biomarker discovery?

Year: 2019

Type: editorial

Abstract: The need continues for new prostate cancer (PCa) biomarkers for use in early detection, recurrence and metastatic disease diagnostics, therapeutic monitoring, and prediction of treatment benefit. A...

Source: Expert Review of Molecular Diagnostics

DOI: 10.1080/14737159.2019.1665507

Authors: Richard R. Drake, Peggi M. Angel, Jennifer Wu, Russell K. Pachynski, Joseph E. Ippolito

Institutions: Medical University of South Carolina, Northwestern University, Washington University in St. Louis

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute on Minority Health and Health Disparities

Awards: Medical University of South Carolina Transdisciplinary Collaborative Center in Precision Medicine and Minority Men's Health, Tumor immune and glycan biomarkers for progressive prostate cancer

OpenAlex ID: W2973048490

Cites: 15

Cited by: 10

Related to: 10